Mutational signatures in tumours induced by high and low energy radiation in Trp53 deficient mice

Yun Rose Li(University of California, San Francisco), Kyle Halliwill(University of California, San Francisco), Cassandra Adams(University of California, San Francisco), Vivek Iyer(Wellcome Sanger Institute), Laura Riva(Wellcome Sanger Institute), Rashid Mamunur(Wellcome Sanger Institute), Kuang‐Yu Jen(University of California, San Francisco), Reyno Del Rosario(University of California, San Francisco), Erik Fredlund(University of California, San Francisco), Gillian L. Hirst(University of California, San Francisco), Ludmil B. Alexandrov(University of California San Diego), David J. Adams(Wellcome Sanger Institute), Allan Balmain(University of California, San Francisco)
Nature Communications
January 20, 2020
Cited by 84Open Access
Full Text

Abstract

Abstract Ionising radiation (IR) is a recognised carcinogen responsible for cancer development in patients previously treated using radiotherapy, and in individuals exposed as a result of accidents at nuclear energy plants. However, the mutational signatures induced by distinct types and doses of radiation are unknown. Here, we analyse the genetic architecture of mammary tumours, lymphomas and sarcomas induced by high ( 56 Fe-ions) or low (gamma) energy radiation in mice carrying Trp53 loss of function alleles. In mammary tumours, high-energy radiation is associated with induction of focal structural variants, leading to genomic instability and Met amplification. Gamma-radiation is linked to large-scale structural variants and a point mutation signature associated with oxidative stress. The genomic architecture of carcinomas, sarcomas and lymphomas arising in the same animals are significantly different. Our study illustrates the complex interactions between radiation quality, germline Trp53 deficiency and tissue/cell of origin in shaping the genomic landscape of IR-induced tumours.


Related Papers

No related papers found

Powered by citation graph analysis